Skip to content
  • Pharma SOP’s
  • Schedule M
  • Pharma tips
  • Pharma Stability Studies

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: FDA 21 CFR Part 211

Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas

Posted on May 18, 2025 By digi

Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas Rejected Units Must Not Be Stored in Dispensing Areas Remember: Rejected materials should be promptly removed from dispensing areas to prevent mix-ups, cross-contamination, or unauthorized usage. Why This Matters in GMP Dispensing areas are reserved for handling approved materials that meet all quality specifications. Keeping rejected…

Read More “Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas” »

GMP Tips

Update GMP Training Records After Every Training Session

Posted on May 17, 2025 By digi

Update GMP Training Records After Every Training Session Always Update Training Records Immediately After GMP Sessions Remember: GMP training records must be filled out, signed, and filed after each session—this is critical for compliance and personnel qualification. Why This Matters in GMP Personnel training is a cornerstone of GMP compliance. Accurate and up-to-date training records…

Read More “Update GMP Training Records After Every Training Session” »

GMP Tips

Never Use Photocopies as Originals for GMP Quality Documents

Posted on May 17, 2025 By digi

Never Use Photocopies as Originals for GMP Quality Documents Do Not Use Photocopies as Original GMP Quality Documents Remember: Only approved, controlled originals should be used for GMP activities—photocopies are not acceptable as quality documents. Why This Matters in GMP Using photocopied documents introduces the risk of working with outdated, unauthorized, or modified content. Without…

Read More “Never Use Photocopies as Originals for GMP Quality Documents” »

GMP Tips

Verify Integrity of Tamper-Evident Seals During Packaging

Posted on May 16, 2025 By digi

Verify Integrity of Tamper-Evident Seals During Packaging Check Tamper-Evident Seals for Integrity During Packaging Remember: Tamper-evident seals must be visually verified during packaging to ensure they are applied correctly and uncompromised. Why This Matters in GMP Tamper-evident packaging is a vital mechanism for protecting pharmaceutical products against manipulation and counterfeiting. These seals serve as visible…

Read More “Verify Integrity of Tamper-Evident Seals During Packaging” »

GMP Tips

Never Use Trial Batches for Commercial Release Under GMP

Posted on May 16, 2025 By digi

Never Use Trial Batches for Commercial Release Under GMP Trial Batches Must Never Be Released for Commercial Sale Remember: Trial or test batches are meant for validation, not market release. Only GMP-compliant commercial batches may be distributed. Why This Matters in GMP Trial batches are manufactured during early development, scale-up, or process validation. They are…

Read More “Never Use Trial Batches for Commercial Release Under GMP” »

GMP Tips

Conduct Routine Gown Integrity Checks in GMP Cleanrooms

Posted on May 15, 2025 By digi

Conduct Routine Gown Integrity Checks in GMP Cleanrooms Perform Routine Gown Integrity Checks in Clean Environments Remember: Cleanroom garments must be regularly checked for damage or wear to prevent microbial or particulate contamination. Why This Matters in GMP Gowning is the first line of defense against contamination in controlled manufacturing environments. Over time, cleanroom gowns—whether…

Read More “Conduct Routine Gown Integrity Checks in GMP Cleanrooms” »

GMP Tips

Prohibit Forklift Use in Primary Packaging Areas to Prevent Contamination

Posted on May 15, 2025 By digi

Prohibit Forklift Use in Primary Packaging Areas to Prevent Contamination Forklifts Must Not Be Operated in Primary Packaging Zones Remember: Forklift usage in clean or primary packaging areas violates GMP zoning and increases contamination and safety risks. Why This Matters in GMP Forklifts are designed for warehouse and bulk material movement—not for cleanroom or primary…

Read More “Prohibit Forklift Use in Primary Packaging Areas to Prevent Contamination” »

GMP Tips

Review Equipment Logbooks for Completeness During GMP Audits

Posted on May 15, 2025 By digi

Review Equipment Logbooks for Completeness During GMP Audits Ensure Equipment Logbooks Are Complete Before Every Audit Remember: Incomplete or inconsistent logbooks can jeopardize audit outcomes—always verify records are complete and current. Why This Matters in GMP Equipment logbooks document the history of usage, cleaning, calibration, and maintenance for every critical asset in a GMP facility….

Read More “Review Equipment Logbooks for Completeness During GMP Audits” »

GMP Tips

Never Rely on Memory to Record GMP Observations or Results

Posted on May 14, 2025 By digi

Never Rely on Memory to Record GMP Observations or Results Document Observations Immediately—Don’t Rely on Memory Remember: All GMP observations and results must be recorded contemporaneously—memory is not a valid data source. Why This Matters in GMP In GMP environments, every observation, measurement, or deviation must be documented at the time it occurs. Delayed entries…

Read More “Never Rely on Memory to Record GMP Observations or Results” »

GMP Tips

Follow Hold Time Studies to Ensure Product Stability and Safety

Posted on May 14, 2025 By digi

Follow Hold Time Studies to Ensure Product Stability and Safety Always Follow Hold Time Studies to Preserve Product Stability Remember: In-process materials must not exceed validated hold times—doing so risks microbial growth and product degradation. Why This Matters in GMP Hold time studies define how long a product or intermediate can be held between manufacturing…

Read More “Follow Hold Time Studies to Ensure Product Stability and Safety” »

GMP Tips

Posts pagination

1 2 … 4 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • GMP Blog
Widget Image
  • Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas

    Do Not Stockpile Rejected Units… Read more

FDA 21 CFR Part 211

  • Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas
  • Update GMP Training Records After Every Training Session
  • Never Use Photocopies as Originals for GMP Quality Documents
  • Verify Integrity of Tamper-Evident Seals During Packaging
  • Never Use Trial Batches for Commercial Release Under GMP
  • Conduct Routine Gown Integrity Checks in GMP Cleanrooms
  • Prohibit Forklift Use in Primary Packaging Areas to Prevent Contamination
  • Review Equipment Logbooks for Completeness During GMP Audits
  • Never Rely on Memory to Record GMP Observations or Results
  • Follow Hold Time Studies to Ensure Product Stability and Safety

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme